Neurodevelopmental and synaptic defects in DNAJC6 parkinsonism, amenable to gene therapy

DNAJC6 encodes auxilin, a co-chaperone protein involved in clathrin-mediated endocytosis (CME) at the presynaptic terminal. Biallelic mutations in DNAJC6 cause a complex, early-onset neurodegenerative disorder characterized by rapidly progressive parkinsonism-dystonia in childhood. The disease is co...

Full description

Saved in:

Bibliographic Details
Published in:	Brain (London, England : 1878) Vol. 147; no. 6; pp. 2023 - 2037
Main Authors:	Abela, Lucia, Gianfrancesco, Lorita, Tagliatti, Erica, Rossignoli, Giada, Barwick, Katy, Zourray, Clara, Reid, Kimberley M, Budinger, Dimitri, Ng, Joanne, Counsell, John, Simpson, Arlo, Pearson, Toni S, Edvardson, Simon, Elpeleg, Orly, Brodsky, Frances M, Lignani, Gabriele, Barral, Serena, Kurian, Manju A
Format:	Journal Article
Language:	English
Published:	England Oxford University Press 03-06-2024
Subjects:	Auxilins - genetics Auxilins - metabolism Child Dopaminergic Neurons - metabolism Endocytosis - genetics Endocytosis - physiology Female Genetic Therapy - methods HSP40 Heat-Shock Proteins - genetics HSP40 Heat-Shock Proteins - metabolism Humans Induced Pluripotent Stem Cells - metabolism Male Mutation Original Parkinsonian Disorders - genetics Parkinsonian Disorders - metabolism Parkinsonian Disorders - therapy Synapses - genetics Synapses - metabolism gene therapy CME auxilin parkinsonism DNAJC6 neurodevelopmental
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	DNAJC6 encodes auxilin, a co-chaperone protein involved in clathrin-mediated endocytosis (CME) at the presynaptic terminal. Biallelic mutations in DNAJC6 cause a complex, early-onset neurodegenerative disorder characterized by rapidly progressive parkinsonism-dystonia in childhood. The disease is commonly associated with additional neurodevelopmental, neurological and neuropsychiatric features. Currently, there are no disease-modifying treatments for this condition, resulting in significant morbidity and risk of premature mortality. To investigate the underlying disease mechanisms in childhood-onset DNAJC6 parkinsonism, we generated induced pluripotent stem cells (iPSC) from three patients harbouring pathogenic loss-of-function DNAJC6 mutations and subsequently developed a midbrain dopaminergic neuronal model of disease. When compared to age-matched and CRISPR-corrected isogenic controls, the neuronal cell model revealed disease-specific auxilin deficiency as well as disturbance of synaptic vesicle recycling and homeostasis. We also observed neurodevelopmental dysregulation affecting ventral midbrain patterning and neuronal maturation. To explore the feasibility of a viral vector-mediated gene therapy approach, iPSC-derived neuronal cultures were treated with lentiviral DNAJC6 gene transfer, which restored auxilin expression and rescued CME. Our patient-derived neuronal model provides deeper insights into the molecular mechanisms of auxilin deficiency as well as a robust platform for the development of targeted precision therapy approaches.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0006-8950 1460-2156 1460-2156
DOI:	10.1093/brain/awae020